HAUS5 and sarcoma: From Fig. 2A, we found that HAUS5 expression significantly affected OS in patients with multiple cancer types, including adrenocortical carcinoma (ACC) (p = 8.90E−04), KIRC (p = 2.70E−05), LGG (p = 3.30E−09), LIHC (p = 1.90E−03), mesothelioma (MESO) (p = 3.10E−03), PRAD (p = 0.02), READ (p = 3.00E−02), sarcoma (SARC) (p = 0.04) and thymoma (THYM) (p = 0.02).